Casdin Capital, LLC Exscientia PLC Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Exscientia PLC stock. As of the latest transaction made, Casdin Capital, LLC holds 213,900 shares of EXAI stock, worth $1.11 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
213,900
Previous 213,900
-0.0%
Holding current value
$1.11 Million
Previous $1.09 Million
-0.0%
% of portfolio
0.09%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding EXAI
# of Institutions
85Shares Held
34.8MCall Options Held
22.8KPut Options Held
178K-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$29.6 Million0.15% of portfolio
-
Sb Global Advisers LTD London, X05.68MShares$29.6 Million3.51% of portfolio
-
Laurion Capital Management LP New York, NY5.14MShares$26.8 Million0.31% of portfolio
-
Baillie Gifford & CO4.4MShares$22.9 Million0.02% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.93MShares$10.1 Million0.4% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $638M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...